Extracellular Matrix Alterations and the Antifibrotic Role of Mycophenolate Mofetil in a Model of Peyronie's Disease.

Authors

Thiago da Silveira Antoniassi, Thalles Fernando Rocha Ruiz, Vitor Grigio, Luiz Roberto Falleiros-Junior, Simone Jacovaci Colleta, Luiz Cesar Fava Spessoto, Sebastião Roberto Taboga, Fernando Nestor Facio-Junior

Published in

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. Pages 221554261484218. Sep 07, 2026. Epub Sep 07, 2026.

Abstract

Peyronie's disease (PD) is a fibrotic disorder of the tunica albuginea marked by extracellular matrix (ECM) remodeling, leading to penile curvature and erectile dysfunction. This study aimed to evaluate ECM alterations in a rat model of PD induced by transforming growth factor beta and to assess the potential antifibrotic effects of mycophenolate mofetil (MMF). Thirty male Wistar rats were divided into control, SHAM, PD (7 and 30 days), and PD+MMF-treated (7 and 30 days) groups (n=5/group). Histological and immunohistochemical analyses were performed in the tunica albuginea. PD induction resulted in an imbalance between total collagen and reticulin fibers, a hallmark of early fibrosis, and increased proteoglycan deposition and elastic fiber disorganization. These changes were more pronounced at 30 days post-induction. MMF treatment for 30 days significantly reduced collagen ratio, restored collagen organization, and normalized the distribution of elastic fibers. Proteoglycan levels, elevated in untreated PD animals, were also decreased after 30 days of MMF therapy. In addition, MMF modulated matrix metalloproteinase (MMP) expressions, notably enhancing MMP-2 and MMP-3 levels, and altered the balance of fibroblasts and myofibroblasts in a time-dependent manner. These findings suggest that MMF has antifibrotic effects and may be a promising therapeutic strategy for PD, particularly in the early stages of fibrosis:°.

PMID:
42706714
Bibliographic data and abstract were imported from PubMed on 08 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.